NCT04111653 (T2BT) is a NA clinical trial of Mud therapy in Mud Therapy, sponsored by Association Francaise pour la Recherche Thermale.

Who is sponsoring NCT04111653?

NCT04111653 is sponsored by Association Francaise pour la Recherche Thermale.

What drugs are being tested in NCT04111653?

Interventions in NCT04111653: Mud therapy.

What condition does NCT04111653 study?

NCT04111653 studies Mud Therapy.

Is NCT04111653 still recruiting?

NCT04111653 is currently status unknown. Last updated 9 July 2020.

Last reviewed 2020-07-09 · How we verify

NCT04111653: T2BT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Exploration of the Transfer of Barium From Thermal Mud

Status unknown NA Last updated 9 July 2020

What this trial tests

NA trial testing Mud therapy in Mud Therapy in 36 participants. Status unknown.

Timeline

13 January 2020

Primary endpoint
30 July 2020

30 September 2020

Quick facts

Lead sponsor	Association Francaise pour la Recherche Thermale
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	36
Start date	13 January 2020
Primary completion	30 July 2020
Estimated completion	30 September 2020
Sites	1 location across France

Drugs / interventions tested

Mud therapy

Conditions studied

Mud Therapy — all drugs for Mud Therapy →

Sponsor

Association Francaise pour la Recherche Thermale

Who can join

Adults 18 to 30, any sex, with Mud Therapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It involves conducting a clinical study on a population of healthy volunteers (age between 18 and 30 years) without direct benefit for the subject to explore a transfer of barium in the blood and urine following applications of thermal mud. The main objective is to highlight an increase in serum barium level of at least twice.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Association Francaise pour la Recherche Thermale trials

Trials by the same sponsor.

NCT07029594 — Thermal Spa Treatment and Improvement of Primary Ciliary Dyskinesia · NA · recruiting
NCT03912623 — Evaluation of the Benefit at 6 Months of a 3 Weeks Spa Treatment in the Type 2 Diabetic Patient. · NA · unknown
NCT03910023 — Non-pharmacological Treatment for Chronic Back Pain · NA · unknown
NCT03550547 — Educational Program Associated With a Conventional Spa Therapy of Knee Osteoarthritis Patients · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04111653 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Association Francaise pour la Recherche Thermale
Last refreshed: 9 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04111653.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing